Eli Lilly is the best of both worlds — a recession-resistant stock with major growth potential

Health, Fitness & Food

Traders work beneath monitors displaying Eli Lilly signage on the floor of the New York Stock Exchange.
Michael Nagle | Bloomberg | Getty Images

The year ahead is pivotal for Eli Lilly (LLY) as the pharmaceutical giant looks to advance drugs in its stellar pipeline. Executives detailed reasons for optimism at a major industry gathering this week.

Articles You May Like

Over Half of ED Visits From Cancer Patients Could Be Prevented
COVID-19 Patients At Higher Risk Of Death For 18 Months After Infection: Study
Gesundheit! Allergies Affect More Than One in Four
New ACC Guidance on Diagnosis, Management of Cardiac Amyloidosis
Researchers solve an 80-year-old medical mystery that causes kidney damage in children

Leave a Reply

Your email address will not be published. Required fields are marked *